Indene derivatives and their use as PAF-antagonists
AssigneeMerck & Co., Inc.
InventorsTsung-Ying Shen, Shu S. Yang, San-Bao Hwang
Life of this patent
Estimating the term…
Abstract
Indene derivatives have been found to have potent and specific PAF (Platelet-Activating-Factor) antagonistic activities and are thereby useful in the treatment of various diseases or disorders mediated by the PAF, for example, inflammation, cardiovascular disorder, asthma, lung edema, and adult respiratory distress syndrome.
Claims9
A compound of formula:
- ##STR23## wherein R.sup.1 is (a) CH.sub.2 COOCH.sub.3
- (b) CH.sub.2 CH.sub.2 OH
- (c) CH.sub.2 CH.sub.2 OCH.sub.3
- (d) CH.sub.2 CH.sub.2 SCH.sub.3
- (e) CH.sub.2 CHSC.sub.2 H.sub.5
- (f) CH.sub.2 CH.sub.2 SC.sub.6 H.sub.5
- (g) CH.sub.2 CH.sub.2 SOCH.sub.3.
A pharmaceutical composition for the treatment of a PAF-mediated disease comprising a pharmaceutical carrier and a therapeutically effective amount of a compound of formula:
- ##STR24## wherein R.sup.1 is (a) CH.sub.2 COOCH.sub.3
- (b) CH.sub.2 CH.sub.2 OH
- (c) CH.sub.2 CH.sub.2 OCH.sub.3
- (d) CH.sub.2 CH.sub.2 SCH.sub.3
- (e) CH.sub.2 CHSC.sub.2 H.sub.5
- (f) CH.sub.2 CH.sub.2 SC.sub.6 H.sub.5
- (g) CH.sub.2 CH.sub.2 SOCH.sub.3.
A method for treating a PAF-mediated disease comprising the administration to a mammalian species in need of such treatment a therapeutically effective amount of a compound of formula:
- ##STR25## wherein R.sup.1 is (a) CH.sub.2 COOCH.sub.3
- (b) CH.sub.2 CH.sub.2 OH
- (c) CH.sub.2 CH.sub.2 OCH.sub.3
- (d) CH.sub.2 CH.sub.2 SCH.sub.3
- (e) CH.sub.2 CHSC.sub.2 H.sub.5
- (f) CH.sub.2 CH.sub.2 SC.sub.6 H.sub.5
- (g) CH.sub.2 CH.sub.2 SOCH.sub.3.
A compound of formula ##STR26## wherein R.sup.1 is CH.sub.2 COOCH.sub.3.
A compound of formula ##STR27## wherein R.sup.1 is (a) CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.3
- (b) CH.sub.2 CH.sub.2 OCH.sub.3.
Dependencies are inferred from the claim text.